MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder

Phase 2
Completed
Conditions
Obsessive-compulsive Disorder
Ocd
Interventions
Drug: placebo
First Posted Date
2007-08-31
Last Posted Date
2020-03-06
Lead Sponsor
Yale University
Target Recruit Count
40
Registration Number
NCT00523718
Locations
🇺🇸

Yale OCD Research Clinic, New Haven, Connecticut, United States

Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons

Phase 4
Completed
Conditions
Obesity
Binge Eating
Interventions
Behavioral: Behavioral intervention + placebo
First Posted Date
2007-08-16
Last Posted Date
2020-04-02
Lead Sponsor
Yale University
Target Recruit Count
79
Registration Number
NCT00516919
Locations
🇺🇸

Hispanic Clinic of the Connecticut Mental Health Center, New Haven, Connecticut, United States

🇺🇸

Yale Department of Psychiatry, New Haven, Connecticut, United States

Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban

Phase 4
Terminated
Conditions
Insomnia
Nicotine Dependence
Interventions
First Posted Date
2007-08-03
Last Posted Date
2022-05-09
Lead Sponsor
Yale University
Target Recruit Count
4
Registration Number
NCT00511134
Locations
🇺🇸

Connecticut Mental Health Center, New Haven, Connecticut, United States

Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers

Phase 1
Completed
Conditions
Nicotine Dependence
Smoking
Interventions
First Posted Date
2007-07-17
Last Posted Date
2018-01-17
Lead Sponsor
Yale University
Target Recruit Count
40
Registration Number
NCT00502216
Locations
🇺🇸

Yale University School of Medicine Substance Abuse Treatment Unit, New Haven, Connecticut, United States

Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir

Not Applicable
Completed
Conditions
HIV Infections
Interventions
Drug: Buprenorphine, Tipranavir and ritonavir
First Posted Date
2007-06-14
Last Posted Date
2020-04-20
Lead Sponsor
Yale University
Target Recruit Count
12
Registration Number
NCT00486330
Locations
🇺🇸

Yale University School of Medicine AIDS Program, New Haven, Connecticut, United States

Anger Control Training for Youth With Tourette Syndrome

Not Applicable
Completed
Conditions
Oppositional Defiant Disorder
Tourette Syndrome
ADHD
Chronic Tic Disorder
First Posted Date
2007-06-14
Last Posted Date
2022-02-11
Lead Sponsor
Yale University
Target Recruit Count
26
Registration Number
NCT00486551
Locations
🇺🇸

Yale University School of Medicine, Child Study Center, New Haven, Connecticut, United States

Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers

Phase 1
Completed
Conditions
Advanced Cancers
Interventions
First Posted Date
2007-05-15
Last Posted Date
2013-01-23
Lead Sponsor
Yale University
Target Recruit Count
15
Registration Number
NCT00473720
Locations
🇺🇸

Yale University, Comprehensive Cancer Center, New Haven, Connecticut, United States

Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism

Phase 3
Completed
Conditions
Alcohol Dependence
Schizophrenia
Interventions
Drug: Placebo
First Posted Date
2007-04-20
Last Posted Date
2020-03-31
Lead Sponsor
Yale University
Target Recruit Count
23
Registration Number
NCT00463346
Locations
🇺🇸

VA Connecticut Healthcare System, West Haven, Connecticut, United States

Galantamine for Cognitive Deficits in Schizophrenia

Phase 2
Completed
Conditions
Schizophrenia
First Posted Date
2007-04-20
Last Posted Date
2007-12-12
Lead Sponsor
Yale University
Target Recruit Count
21
Registration Number
NCT00463879
Locations
🇺🇸

Connecticut Mental Health Center, Yale School of Medicine, New Haven, Connecticut, United States

Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma

Phase 2
Completed
Conditions
Bladder Cancer
Interventions
First Posted Date
2007-04-18
Last Posted Date
2017-12-14
Lead Sponsor
Yale University
Target Recruit Count
17
Registration Number
NCT00461851
Locations
🇺🇸

Yale University, Comprehensive Cancer Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath